Vaccines protect us from the new SARS-CoV-2 strains as well, Secretary of State with the Health Ministry Andrei Baciu informed on Monday, quoting a British study.
“Vaccines protect us from the new SARS-CoV-2 strains! A British study published in “The Lancet” medical journal shows that fully vaccinated persons with the Pfizer/BioNTech and Oxford/AstraZeneca serums have developed antibodies capable to neutralise the Delta (India) strain of the novel coronavirus,” Baciu writes on his Facebook page.
According to the Secretary of State, it is important that the body produces the necessary antibodies and detects this coronavirus mutation.
“Unfortunately, in Romania there have already been 35 persons infected with the Delta strain of the SARS-CoV-2,” Andrei Baciu also says.
Vaccination campaign: 20,040 persons immunized in the past 24 hours, 6810 with the first jab
In the last 24 hours, 20,040 doses of vaccine against SARS-CoV-2 were administered, of which 16,283 – Pfizer, 2,332 – Johnson & Johnson, 662 – Moderna and 763 – AstraZeneca, according to a report sent by the National Committee Coordinating COVID-19 Vaccination Activities (CNCAV).
CNCAV shows that, in the same interval, 6,810 people were vaccinated with the first dose and 13,230 with the second one.
Since December 27, 2020, 8,756,809 vaccine doses have been administered to 4,640,330 people, of whom 269,637 received a dose and 4,370,693 and a second one as well.
In the last 24 hours, 5 side effects have been reported, all of a general nature.
Since the start of the vaccination campaign, there have been 16,500 adverse reactions to COVID vaccines, 1,773 local and 14,727 general.
According to CNCAV, 146 side effects are under investigation.
CNCAV: New tranche of AstraZeneca vaccine will arrive on Tuesday
A number of 208,800 doses of the Vaxzevria (AstraZeneca) vaccine will arrive on Tuesday at the “Cantacuzino” National Institute for Medical-Military Research and Development, informs the National Coordinating Committee on COVID-19 Vaccination Activities (CNCAV).
According to the quoted source, transport is provided by the manufacturing company, and the vaccine doses will be brought to Bucharest by land.
“The doses will be stored at the National Storage Centre, and in the next period they will be distributed to the existing regional centres nationwide. The National Storage Centre for vaccines against COVID-19 within the “Cantacuzino” Institute is fully authorised and approved by the National Agency for Medicines and Medical Devices of Romania (ANMDMR), the national authority that has competence in the field of medicine for human use,” states the same source.
To date, Romania has received 3,165,200 doses of the vaccine produced by the AstraZeneca pharmaceutical company, and since February 15, 835,780 doses have already been used to immunise the population.